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Abstract 
The optimal stimulus to repair or regenerate cartilage is not known. We therefore 
modulated collagen deposition, collagen cross-linking and GAG deposition 
simultaneously during cartilage matrix production and integrative repair, creating 
more insight in their role in cartilage repair processes.  
Insuline-like Growth Factor 1 (IGF-1, increases proteoglycan and collagen synthesis), 
Beta-aminopropionitrile (BAPN, a reversible inhibitor of collagen crosslinking) and 
para-nitrophenyl-beta-d-xyloside (PNPX, interferes with proteoglycan production) 
were used. Bovine articular chondrocytes were cultured in alginate beads for three 
weeks with or without IGF-1, BAPN or PNPX alone and in all possible combinations 
followed by three weeks in control medium. DNA content, GAG and collagen 
deposition and collagen cross-links were determined. Cartilage constructs were 
cultured under same conditions and histologically analysed for integration of two 
opposing cartilage matrices.  
In alginate cultures, inhibition of collagen cross-linking with BAPN in combination with 
promotion of matrix synthesis using IGF1 was most beneficial for matrix deposition. 
Addition of PNPX was always detrimental for matrix deposition. For integration of 
opposing cartilage constructs, the combination of BAPN, IGF1 and temporary prevention 
of proteoglycan formation with PNPX was most beneficial.  
When a new matrix is produced, proteoglycans are important to retain collagen in the 
matrix. When two already formed cartilage matrices have to integrate, temporary 
absence of proteoglycans and temporary inhibition of collagen cross-linking might be 
more beneficial in combination with stimulation of collagen production by for example 
IGF1. Therefore, the choice of soluble factors to promote cartilage regeneration 
depends on the type of therapy that will be used. 
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1. Introduction 
Once damaged, adult articular cartilage has a poor repair capacity, which is probably 
due to the ineffective repair of the collagen network, since proteoglycan depletion is 
often reversible (Lafeber 1992). Although collagen turnover is increased in osteoarthritis 
(OA), this does not lead to the formation of a functional network (Aigner 1993; 
Billinghurst 1997; Nelson 1998; Verzijl 2000). This suggests an activated repair 
mechanism in OA that appears however ineffective in repairing or maintaining the 
ECM homeostasis.  
Several strategies are under investigation to promote matrix regeneration in cartilage 
repair. Growth factors are used to modulate matrix production, by directly adding 
them to chondrocytes in culture (Gooch 2002; Veilleux 2005) or by inducing over 
expression of the growth factor of interest (Madry 2002; Kaul 2006). For example, we 
and others found that addition of IGF1 to chondrocytes in culture resulted in more 
proteoglycans and collagen than in the control condition without IGF1 (Blunk 2002; 
Mauck 2003; De Mattei 2004; Jenniskens 2006) 
In addition to growth factors, modulation of collagen network formation is also 
employed to understand cartilage matrix formation and functionality, for example by 
the inhibition of collagen cross-linking by inhibition of lysyl oxidase (LOX) with β-
aminopropionitrile (BAPN). It was found that collagen cross-links are important for the 
integrative repair and adhesive strength of cartilage (DiMicco 2002) and that transient 
inhibition of the formation of these cross-links improved integrative repair and 
collagen cross-link maturation (McGowan 2005). In cultures of chondrocytes in 
alginate, inhibition of collagen cross-link formation with BAPN resulted in an increase 
of collagen production (Beekman 1997; Wong 2002; Bastiaansen-Jenniskens 
2008a). In concordance with earlier explant studies (McGowan 2005), transient 
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inhibition of LOX in alginate cultures resulted in accelerated cross-link maturation and 
improved functionality of the newly formed matrix (Bastiaansen-Jenniskens 2008a).  
The influence of glycosaminoglycans (GAGs) on cartilage growth and matrix 
production is also under investigation, but gets less attention than collagen. GAG 
depletion in cartilage explants resulted in less expansive growth and a more mature 
matrix with increased tensile integrity (Asanbaeva 2007). Preventing GAGs from 
binding to the proteoglycan core protein with para-nitrophenyl xyloside (PNPX) in the 
newly forming cartilage matrix of chondrocytes cultured in alginate resulted in less 
collagen deposition and a decrease in stiffness and ability to hold water 
(Bastiaansen-Jenniskens 2008b). The difference between these two studies is that in 
the explant study collagen was already deposited and cross-linked, whereas in the 
alginate cultures no collagen was yet deposited when GAG incorporation was 
inhibited. Both studies however indicate that modulating GAGs can influence the 
collagen network in an already existing cartilage matrix or during new cartilage matrix 
synthesis. 
Most of the approaches mentioned above focused on modulating one matrix 
component (either collagen or proteoglycans). However, increasing collagen 
synthesis alone is not sufficient for cartilage repair. Because of the differential and 
potentially complementary effects of these approaches, our hypothesis was that 
combining IGF1, BAPN and PNPX in one experiment has the potential to stimulate 
matrix production and integrative repair more than each single component. 
Chondrocytes cultured in alginate were used to examine the effect of the soluble 
factors on new matrix production, either alone or in all possible combinations. 
Cartilage explants were used to examine the effect of the factors mentioned above 
on integration of two existing cartilage matrices. 
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2. Materials and Methods 
2.1 Cell culture 
Articular cartilage was harvested from the metacarpophalangeal joints of calves aged 
6–12 months. Chondrocytes were isolated, suspended in alginate in a concentration 
of 4 x 106 cells per mL of alginate, and alginate beads were made as described 
previously (Jenniskens 2006). Beads were cultured in a six-well plate (BD Falcon, 
Bedford, MA, USA), with 75 µl/bead DMEM/F12 supplemented with 10% fetal bovine 
serum (GibcoBRL), 50 µg/ml L-asorbic acid 2-phosphate (Sigma), 50 µg/ml 
gentamicin and 1.5 µg/ml fungizone (both GibcoBRL). Chondrocytes were cultured 
for 21 days in the presence of 25 ng/ml IGF-1, 0.25 mM BAPN and/or 0.25 mM 
PNPX based on previous results (Jenniskens 2006; Bastiaansen-Jenniskens 2008a; 
Bastiaansen-Jenniskens 2008b) followed by 21 days in control medium. As known 
from these previous studies, BAPN inhibits collagen cross-linking and PNPX prevents 
incorporation of GAGs into the matrix. In the 21 days of additional culture without 
supplements, cross-links had the ability to form and GAGs to incorporate into the 
matrix. Culture medium was changed three times a week. Alginate beads were 
harvested after 42 days of culture. 
 
2.2 Preparation of cartilage explants for integration study 
Articular cartilage samples were harvested from the metacarpophalangeal joints of 
calves aged 6–12 months. Full-thickness cartilage explants of 8 mm diameter and 
with a thickness of 0.9–1.2 mm were prepared using a dermal biopsy punch and 
scalpel. From the centre of the explants, 3-mm cores were punched out. All samples 
(both outer ring and inner core) were incubated for 24 hours in 10 U/ml highly purified 
collagenase VII (Sigma-Aldrich Chemie BV, Zwijndrecht, The Netherlands) in DMEM-
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F12 with 10% fetal calf serum based on previous results (Bos 2002; van de Breevaart 
Bravenboer 2004; Janssen 2006). From the study of Bos et al (Bos 2002), it was 
concluded that there is some loss of matrix proteins by digesting for 24 hours with 
highly purified collagenase, but only on the locations where proteoglycans are lost, 
i.e. the area of the wound edge. Pre-treatment with collagenase is beneficial for 
integration because it increases the number of viable cells at the wound edge 
thereby enabling integration of the wound edges. All the cartilage explants were pre-
treated with the collagenase irrespective of the condition. After incubation, the 
samples were washed three times for 10 min in culture medium, and the 3-mm inner 
cores were reimplanted in their accompanying 8-mm outer rings. Constructs were 
cultured in parallel to the alginate beads for 21 days in the presence of 25 ng/ml IGF-
1, 0.25 mM BAPN and/or 0.25 mM PNPX followed by 21 days in control medium.  
Constructs were cultured in 1.5 ml DMEM/F12 per construct supplemented with 10% 
fetal bovine serum (GibcoBRL), 50 µg/ml L-asorbic acid 2-phosphate (Sigma), 50 
µg/ml gentamicin and 1.5 µg/ml fungizone (both GibcoBRL) in the presence of 25 
ng/ml IGF-1, 0.25 mM BAPN and/or 0.25 mM PNPX during the first 21 days. After 42 
days, constructs were harvested an immediately fix d in 4% phosphate buffered 
formalin. 
 
2.3 Biochemical analysis of alginate beads 
Alginate beads were digested overnight at 56°C in papain buffer (250 µg/ml papain in 
50 mM EDTA and 5 mM L-cysteine). Glycosaminoglycan (GAG) amount in the digest 
was quantified using dimethylmethylene blue (DMB) assay (Farndale 1986). The 
metachromatic reaction of GAG with DMB was monitored with a spectrophotometer, 
and the ratio A530:A590 was used to determine the amount of GAG present, using 
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chondroitin sulfate C (Sigma) as a standard. The amount of DNA in each papain-
digested sample was determined using ethidium bromide with calf thymus DNA 
(Sigma) as a standard. High-performance liquid chromatography (HPLC) of amino 
acids (hydroxyproline, Hyp) and collagen cross-links (hydroxylysylpyridinoline, HP) 
was performed as described previously (Bank 1996; Beekman 1997). The quantities 
of cross-links were expressed as the number of residues per collagen molecule, 
assuming 300 Hyp residues per collagen triple helix. Three samples were taken of 7 
alginate beads per experimental condition for biochemical analyses. 
 
2.4 Histochemical analysis of cartilage explants 
Formalin fixed cartilage constructs were embedded in paraffin. To prevent any 
negative influence of processing the constructs for histological analysis, separate 
cartilage constructs were placed in little porous polymer bags directly after harvesting 
prior to fixation in formalin and processing. However, a certain risk of damage during 
histological procedure is unavoidable. Therefore we embedded all the samples at the 
same time and did the sectioning in a random order to exclude bias.  Sections (6 µm) 
were cut using a standard microtome. Prior to the histological stainings, sections 
were deparaffinated in xylene and rehydrated through graded ethanol. For 
histological evaluation, serial sections were stained with Hematoxylin & Eosin (H&E). 
To evaluate integration, paraffin sections were stained with a thionine staining. For 
each sample we assessed the percentage of total interface length that had a matrix–
matrix connection. A clear distinction could be made between parts with a matrix 
connection and parts of the cartilage touching each other but without a clearly 
connected matrix, which were scored as parts with a gap. Integration was determined 
at both integration sites within a paraffin section. Interface integration percentages 
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were obtained by two blinded observers from measurements of three to four different 
sections from each sample, resulting in an average value for each interface.  
 
2.5 Statistical analysis 
For the alginate bead cultures and the integration study, four pooled cartilage donors 
were used. Statistical analysis was performed using GraphPad Prism 5.01 
(GraphPad Software, San Diego, CA, USA) software. All data are presented as mean 
± standard deviation. Control groups and groups supplemented with PNPX, BAPN 
and/or IGF1 were compared with a ANOVA test followed by a post hoc Bonferroni 
test.  
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3. Results 
3.1 Chondrocytes cultured in alginate 
After 42 days, DNA content, GAG deposition, collagen deposition and collagen cross-
linking were determined in the alginate beads. In the control condition, DNA content 
was 0.49 ± 0.03 µg DNA per alginate bead, which was unaffected by the addition of 
BAPN, IGF1 and or PNPX during the first 21 days of culture (Figure 1). 
4.38 ± 0.39 µg GAG per bead was deposited in the control condition after 42 days of 
culture. As expected, this was significantly reduced in the condition with 0.25 mM 
PNPX during the first 21 days. Compared to the control condition, GAG deposition 
was also less when a combination of PNPX and IGF1 was present, when PNPX and 
BAPN were present together, and when all three components were present in the 
culture medium. BAPN or IGF1 alone did not influence GAG deposition, rather their 
combination resulted in more GAG deposition (Figure 2). 
Regarding the collagen deposition, 6.16 ± 0.91 µg was deposited in the control 
condition after 42 days. The presence of PNPX during the first 21 days resulted in 
less collagen deposition. Inhibition of collagen cross-link formation with BAPN on the 
other hand resulted in more collagen deposition, as xpected. BAPN together with 
IGF1 increased the collagen deposition even more (Figure 3).  
The presence of BAPN alone, BAPN with IGF1, BAPN with PNPX and all three 
factors during the first 21 days resulted in less cross-link formation, in line with the 
LOX inhibition by BAPN. Addition of IGF1 alone, PNPX alone or PNPX with IGF1 did 
not change the number of collagen cross-links from the control condition, which was 
0.69 ± 0.03 HP per collagen triple helix (Figure 4). 
 
3.2 Cartilage integration 
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In parallel to the alginate cultures, cartilage explants were cultured to investigate the 
integrative capacity in the presence of PNPX, BAPN and/or IGF1. As in the alginate 
cultures, soluble factors were only present during the first 21 days of culture followed 
by culture in control medium for an additional 21 days. Typical examples of 
integration after 42 days visualised with a thionine staining are shown in figure 5. The 
average integration percentage in the control condition was less than 10%. Only 
when PNPX, BAPN and IGF1 were combined during the first 21 days, integration of 
the two opposing cartilage explants improved to 41.3 ± 31.4% (p < 0.05). Although 
not reaching statistical significance, the presence BAPN and IGF1 alone or together 
also seems beneficial for integration.  
Page 10 of 26
http://mc.manuscriptcentral.com/term
Journal of Tissue Engineering and Regenerative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
YM Bastiaansen-Jenniskens; combining IGF-1, BAPN, PNPX 11/20 
4. Discussion 
Many factors have been demonstrated to be able to influence proteoglycan production, 
collagen production or both. However, it is not fully known what the optimal balance of 
collagen and proteoglycan production is and how they influence each other to form a 
functional network. 
Our goal was to examine the effect of modulating collagen deposition, collagen 
cross-linking and GAG deposition simultaneously during cartilage matrix production 
and cartilage integrative repair, thereby creating a wider insight in the role of 
proteoglycans and collagen in cartilage repair process.  
In the alginate cultures, inhibition of collagen cross-linking with BAPN in combination 
with promotion of matrix synthesis using IGF1 was most beneficial for matrix 
deposition. Additional PNPX was always detrimental for matrix deposition. For 
integration, the combination of BAPN, IGF1 and temporary prevention of 
proteoglycan formation with PNPX was most beneficial. 
Inhibition of GAGs from binding to the proteoglycan core protein not only resulted in 
less GAG deposition in the alginate bead, but also in less collagen deposition. This is 
in concordance to our previous study were the presence of PNPX during a culture 
period of 35 days resulted in less proteoglycan and collagen deposition in the 
alginate bead. In addition, excretion of both matrix proteins into the culture medium 
was higher due to the absence of an intact matrix network (Bastiaansen-Jenniskens 
2008b). Because of the absence of this network and the loss of interaction with other 
matrix components, combining PNPX with BAPN and/or IGF1 could not counteract 
the effects seen with PNPX alone. Earlier we found that the inhibition of collagen 
cross-linking in an alginate culture for 21 days and longer results in higher collagen 
deposition then when cross-links are formed. During this culture period, proteoglycan 
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deposition was unaffected (Bastiaansen-Jenniskens 2008a). Even though cross-link 
inhibition by BAPN stimulates collagen synthesis, the retention of collagen is very low 
because of the absence of a proteoglycan network. Previously, we and others 
showed stimulating effects of IGF1 on collagen and proteoglycan deposition (Blunk 
2002; Mauck 2003; De Mattei 2004; Jenniskens 2006). In the present setup, culture 
with IGF1 alone for 21 days did not significantly stimulate matrix deposition after 42 
days, whereas IGF1 did previously already after 21 days (Jenniskens 2006). 
However, the combination IGF1 and BAPN increased GAG deposition which is 
probably attributable to the presence of IGF1 since BAPN does not affect the GAG 
deposition. Even though IGF1 might have also stimulated GAG and collagen 
deposition when combined with PNPX or with PNPX and BAPN, GAGs were 
prevented from incorporation into the matrix. A possible positive effect of IGF1 on 
collagen synthesis was counteracted because of low collagen retention in the 
alginate bead. In every condition where the cross-link inhibitor BAPN was present for 
the first 21 days, less collagen cross-links were present even though the culture 
continued for 21 days after removal of BAPN. This might be explained by the fact that 
after removal of BAPN, it takes three weeks for mature HP cross-links to be formed 
(Ahsan 2005). In addition, BAPN binds irreversibly to lysyl oxidase (LOX) (Tang 
1983) and therefore extra time is also needed for LOX to be produced again. Based 
on our previous experiments, we expect that the number of collagen cross-links will 
be equal in all conditions when a longer culture period is used (Bastiaansen-
Jenniskens 2008a). 
The combination of BAPN and IGF1 seems most beneficial for matrix synthesis when 
no matrix is formed yet, as in the alginate cultures. When aiming at the integration of 
two existing cartilage matrices, cross-link inhibition with BAPN and stimulation of 
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matrix production with IGF1 is not sufficient to significantly improve integration. 
Transient inhibition of GAG incorporation in the matrix with PNPX in combination with 
BAPN and IGF1 did improve the integration. In these experiments, stimulation of 
matrix production alone with IGF1 had no effect. Transient inhibition of collagen 
cross-link formation could have resulted in more collagen synthesis, and in addition in 
better penetration of the newly formed collagen fibres in the opposing tissue that was 
partly depleted of GAGs following injury (Bos 2001). The latter is more likely since 
previous experiments with BAPN and cartilage explants did not result in more 
collagen synthesis (McGowan 2005). The study by McGowan et al is also in 
concordance with the theory of better integration after BAPN treatment. The addition 
of PNPX and the resulting absence of GAG attachment to the proteoglycan core 
protein might have similar effects as seen with inhibition of cross-link formation. 
Without an intact proteoglycan network at the edges of the cartilage explants, newly 
formed collagen fibres might penetrate better into the opposing cartilage tissue. 
Because of the absence of a proteoglycan network, the collagen network might also 
have a better integrity (Asanbaeva 2007). This explains why the presence of IGF1 
with PNPX or BAPN did not improve integration since the newly formed collagen 
stimulated by IGF1 could not penetrate into the cartilage. PNPX together with BAPN 
but without IGF1 was also not sufficient because of the absence of increased 
collagen production.  
When cartilage transplantations are performed, the surgeon removes the damaged 
cartilage first. Removing the damaged cartilage will create a fresh wound area, 
similar to our experimental condition. We hypothesize that the integrative capacity of 
such an area is different from a long lasting wound area and we are therefore 
convinced that our explant model is close to the application in this respect. 
Page 13 of 26
http://mc.manuscriptcentral.com/term
Journal of Tissue Engineering and Regenerative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
YM Bastiaansen-Jenniskens; combining IGF-1, BAPN, PNPX 14/20 
The cartilage explants used for integration were cultured for 6 weeks in vitro. In an 
earlier study, we investigated the effect of improved integration on mechanical 
properties of the cartilage-cartilage interface (van de Breevaart Bravenboer 2004). 
There we observed a relation between the area of integration on histology and the 
mechanical properties of the interface. Since the previous study is performed after an 
in vivo culture period and our current study evaluates after in vitro culture, it is difficult 
to extrapolate these results. Earlier attempts in the lab have demonstrated us that 
after in vitro culture the bonding is not strong enough to measure reliably in our 
system. However, the improved histological integration in the present studies looks 
promising and suggests that when a construct is placed in vivo after modulation with 
our soluble factors (IGF1, PNPX and BAPN), integration might lead to functional 
cartilage. 
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5. Conclusions 
Based on these results, combining IGF1 and cross-link inhibition with BAPN seems 
to be most promising in promoting the formation of a new cartilage matrix. When a 
new matrix is produced, proteoglycans are important to retain collagen in the matrix. 
When two already formed cartilage matrices have to integrate, the temporary 
absence of a proteoglycan network and the temporary absence of collagen cross-
links might be more beneficial in combination with stimulation of collagen production 
by for example IGF1. Therefore, the choice of soluble factors to promote cartilage 
regeneration in OA depends on the type of therapy that will be used. In the case of 
cell therapy and the synthesis of a new matrix, stimulating both collagen and 
proteoglycan synthesis is important. The intra-articular administration of growth 
factors such as IGF1 to promote matrix production is the topic of ongoing research 
(Madry 2005) and could be a part of future OA therapy. When two cartilage matrices 
have to integrate, temporary inhibition of proteoglycan network formation and 
collagen cross-linking together with stimulating collagen production results in better 
integration. In the case of autologous cartilage transplantation, the transplant can be 
pre-treated with hyaluronidase or chondroitinase to remove the proteoglycans and be 
subjected to temporary collagen cross-link inhibition. To generate a tissue 
engineered cartilage construct, culture in the presence of IGF1 and BAPN might be a 
promising approach. However, care must be taken with BAPN since it is mutagenic. 
Other approaches to inhibit collagen cross-linking might be the topic of future 
research. 
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Figure legends 
Figure 1, DNA content of the alginate beads after 42 days of culture. PNPX (P), 
BAPN (B) and/or IGF1 (I) were present in the first 21 days of culture, followed by 
additional culture for 21 days in control medium. Data are shown as mean DNA 
content per bead ± sd. N=3. 
 
Figure 2, GAG content of the alginate beads after 42 days of culture. PNPX (P), 
BAPN (B) and/or IGF1 (I) were present in the first 21 days of culture, followed by 
additional culture for 21 days in control medium. Data are shown as mean GAG 
content per bead ± sd. N=3. * indicates a significant difference  (p<0.05) from the 
control condition without additives. 
 
Figure 3, Collagen content of the alginate beads after 42 days of culture. PNPX (P), 
BAPN (B) and/or IGF1 (I) were present in the first 21 days of culture, followed by 
additional culture for 21 days in control medium. Data are shown as mean collagen 
content per bead ± sd. N=3. * indicates a significant difference (p<0.05) from the 
control condition without additives. 
 
Figure 4, Number of HP cross-links per collagen triple helix after 42 days of culture. 
PNPX (P), BAPN (B) and/or IGF1 (I) were present in the first 21 days of culture, 
followed by additional culture for 21 days in control medium. Data are shown as 
mean HP per collagen triple helix ± sd. N=3. * indicates a significant difference 
(p<0.05) from the control condition without additives. 
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Figure 5, Examples of integration visualised with a thionine staining. A) 20% 
integration in a control sample, B) 70% integration in a sample where PNPX, BAPN 
and IGF1 were present for the first 21 days. Arrows indicate integration, arrowheads 
indicate no integration. Magnification is 40x.  
 
Figure 6, Percentage of integration of opposing cartilage tissue. PNPX (P), BAPN (B) 
and/or IGF1 (I) were present in the first 21 days of culture, followed by additional 
culture for 21 days in control medium. Data are shown as individual percentages with 
the mean percentage ± sd. N=8. * indicates a significant difference (p<0.05) from the 
control condition without additives.  
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